Protein & Peptide Letters
Title:EBMs Special Issue Part - 2
Volume: 26 Issue: 8
Author(s): Ben M. Dunn
Affiliation:
Export Options
About this article
Cite this article as:
Dunn M. Ben , EBMs Special Issue Part - 2, Protein & Peptide Letters 2019; 26 (8) . https://dx.doi.org/10.2174/092986652608190911113642
DOI https://dx.doi.org/10.2174/092986652608190911113642 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
13
1
1
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Computational Analysis and Functional Prediction of Ubiquitin Hypothetical Protein: A Possible Target in Parkinson Disease
Central Nervous System Agents in Medicinal Chemistry GSK3 Inhibitors and Disease
Mini-Reviews in Medicinal Chemistry Cow’s Milk Allergy: Where have we Come from and where are we Going?
Endocrine, Metabolic & Immune Disorders - Drug Targets Levosimendan Reduces Prostaglandin F2a-dependent Vasoconstriction in Physiological Vessels and After Experimentally Induced Subarachnoid Hemorrhage
Current Neurovascular Research G-Quadruplex Interacting Agents Targeting the Telomeric G-Overhang Are More than Simple Telomerase Inhibitors
Current Medicinal Chemistry - Anti-Cancer Agents Antioxidant and Enzyme Inhibitory Properties of Mangifera indica leaf Extract
The Natural Products Journal PUFA for Prevention and Treatment of Dementia?
Current Pharmaceutical Design Epigenetics in Alzheimers Disease: a Focus on DNA Modifications
Current Pharmaceutical Design Learning from the Past: A Review of Clinical Trials Targeting Amyloid, Tau and Neuroinflammation in Alzheimer’s Disease
Current Alzheimer Research Current Therapeutic Advances in Patients and Experimental Models of Huntington's Disease
Current Drug Targets Neurotoxicity of Pesticides: The Roadmap for the Cubic Mode of Action
Current Medicinal Chemistry The Role of Catechol-O-Methyltransferase in Reward Processing and Addiction
CNS & Neurological Disorders - Drug Targets A Community Outreach and Education Model for Early Identification of Mental Illness in Young People
Adolescent Psychiatry Increase of EEG Alpha3/Alpha2 Power Ratio Detects Inferior Parietal Lobule Atrophy in Mild Cognitive Impairment
Current Alzheimer Research Cytokine-Purine Interactions in Traumatic Stress, Behavioral Depression,and Sickness
CNS & Neurological Disorders - Drug Targets Sodium Hydrosulfide Attenuates Beta-Amyloid-Induced Cognitive Deficits and Neuroinflammation via Modulation of MAPK/NF-κB Pathway in Rats
Current Alzheimer Research An Overview of Notch Signaling in Adult Tissue Renewal and Maintenance
Current Alzheimer Research Commentary (Research Highlights: Wnt-Signalling: A New Direction for Alzheimer Disease?)
CNS & Neurological Disorders - Drug Targets Recent Advances in Medicinal Chemistry to Treat Filariasis and Helminthiasis
Current Topics in Medicinal Chemistry Intergenerational Transmission of DNA Methylation Signatures Associated with Early Life Stress
Current Genomics